EDIT
EDIT
NASDAQ · Biotechnology

Editas Medicine Inc

$1.82
+0.16 (+9.31%)
As of Feb 8, 2:06 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 28.87M 30.54M 27.97M
Net Income 5.42M 4.38M 4.75M
EPS
Profit Margin 18.8% 14.4% 17.0%
Rev Growth -3.2% +16.6% +5.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 60.55M 59.55M 55.44M
Total Equity 106.43M 93.22M 102.72M
D/E Ratio 0.57 0.64 0.54
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 9.70M 9.59M 9.00M
Free Cash Flow 5.96M 5.15M 6.45M